Orin Hirschman 13D and 13G filings for Evoke Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-29 7:47 pm Sale | 2024-10-29 | 13G | EVOKE PHARMA INC PAR $0.00 EVOK | Orin Hirschman | 0 0.000% | -70,583 (Position Closed) | Filing |